Diego Lucero

A New Equation Based on the Standard Lipid Panel for Calculating Small Dense Low-Density Lipoprotein-Cholesterol and Its Use as a Risk-Enhancer Test

Maureen Sampson, Anna Wolska, Russell Warnick et al. · Clinical Chemistry · 2021 · 85 citations · Full text

New evidence for the therapeutic potential of curcumin to treat nonalcoholic fatty liver disease in humans

María Eugenia Inzaugarat, Elena De Matteo, Plácida Baz et al. · PLoS ONE · 2017 · 65 citations · Full text

Hepatic lipase activity is increased in non‐alcoholic fatty liver disease beyond insulin resistance

Verónica Miksztowicz, Diego Lucero, Valeria Zago et al. · Diabetes/Metabolism Research and Reviews · 2012 · 49 citations

Nonalcoholic fatty liver disease associated with metabolic syndrome: Influence of liver fibrosis stages on characteristics of very low-density lipoproteins

Diego Lucero, Verónica Miksztowicz, Gisela Gualano et al. · Clinica Chimica Acta · 2017 · 38 citations · Full text

Obesity, Metabolic Syndrome, Metabolic Associated Steatohepatitis +14

Pro-inflammatory and atherogenic circulating factors in non-alcoholic fatty liver disease associated to metabolic syndrome

Diego Lucero, Valeria Zago, Graciela López et al. · Clinica Chimica Acta · 2010 · 36 citations

Metabolic Disorder, Pathology, Fatty Liver Disease +17